157 related articles for article (PubMed ID: 9773881)
1. Quantitation of CD38 expression using QuantiBRITE beads.
Iyer SB; Hultin LE; Zawadzki JA; Davis KA; Giorgi JV
Cytometry; 1998 Oct; 33(2):206-12. PubMed ID: 9773881
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator.
Hultin LE; Matud JL; Giorgi JV
Cytometry; 1998 Oct; 33(2):123-32. PubMed ID: 9773872
[TBL] [Abstract][Full Text] [Related]
3. Multisite comparison of methods for the quantitation of the surface expression of CD38 on CD8(+) T lymphocytes. The ACTG Advanced Flow Cytometry Focus Group.
Schmitz JL; Czerniewski MA; Edinger M; Plaeger S; Gelman R; Wilkening CL; Zawadzki JA; Wormsley SB
Cytometry; 2000 Jun; 42(3):174-9. PubMed ID: 10861690
[TBL] [Abstract][Full Text] [Related]
4. Surface antigen detection with non-fluorescent, antibody-coated microbeads: an alternative method compatible with conventional fluorochrome-based labeling.
Fortin M; Hugo P
Cytometry; 1999 May; 36(1):27-35. PubMed ID: 10331624
[TBL] [Abstract][Full Text] [Related]
5. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
Liu Z; Cumberland WG; Hultin LE; Prince HE; Detels R; Giorgi JV
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):83-92. PubMed ID: 9358102
[TBL] [Abstract][Full Text] [Related]
6. Performance evaluation of QuantiBRITE phycoerythrin beads.
Pannu KK; Joe ET; Iyer SB
Cytometry; 2001 Dec; 45(4):250-8. PubMed ID: 11746094
[TBL] [Abstract][Full Text] [Related]
7. Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up.
Liu Z; Hultin LE; Cumberland WG; Hultin P; Schmid I; Matud JL; Detels R; Giorgi JV
Cytometry; 1996 Mar; 26(1):1-7. PubMed ID: 8809474
[TBL] [Abstract][Full Text] [Related]
8. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
Lenkei R; Bratt G; Holmberg V; Muirhead K; Sandström E
Cytometry; 1998 Oct; 33(2):115-22. PubMed ID: 9773871
[TBL] [Abstract][Full Text] [Related]
9. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
[TBL] [Abstract][Full Text] [Related]
10. CD38 expression on CD8(+) T cells as a prognostic marker in vertically HIV-infected pediatric patients.
Sherman GG; Scott LE; Galpin JS; Kuhn L; Tiemessen CT; Simmank K; Meddows-Taylor S; Meyers TM
Pediatr Res; 2002 Jun; 51(6):740-5. PubMed ID: 12032270
[TBL] [Abstract][Full Text] [Related]
11. CD38 expression on cryopreserved CD8+ T cells predicts HIV disease progression.
Perfetto SP; Malone JD; Hawkes C; McCrary G; August B; Zhou S; Garner R; Dolan MJ; Brown AE
Cytometry; 1998 Oct; 33(2):133-7. PubMed ID: 9773873
[TBL] [Abstract][Full Text] [Related]
12. Differential susceptibility of resting CD4(+) T lymphocytes to a T-tropic and a macrophage (M)-tropic human immunodeficiency virus type 1 is associated with their surface expression of CD38 molecules.
Horikoshi H; Kinomoto M; Sasao F; Mukai T; Luftig RB; Ikuta K
Virus Res; 2001 Jan; 73(1):1-16. PubMed ID: 11163640
[TBL] [Abstract][Full Text] [Related]
13. CD38 in health and disease.
Bofill M; Borthwick NJ
Chem Immunol; 2000; 75():218-34. PubMed ID: 10851787
[No Abstract] [Full Text] [Related]
14. Determination of CD4 antigen density on cells: role of antibody valency, avidity, clones, and conjugation.
Davis KA; Abrams B; Iyer SB; Hoffman RA; Bishop JE
Cytometry; 1998 Oct; 33(2):197-205. PubMed ID: 9773880
[TBL] [Abstract][Full Text] [Related]
15. CD38 in T- and B-cell functions.
Deterre P; Berthelier V; Bauvois B; Dalloul A; Schuber F; Lund F
Chem Immunol; 2000; 75():146-68. PubMed ID: 10851783
[No Abstract] [Full Text] [Related]
16. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
[TBL] [Abstract][Full Text] [Related]
17. Discrepancy in measuring CD4 expression on T-lymphocytes using fluorescein conjugates in comparison with unimolar CD4-phycoerythrin conjugates.
Wang L; Abbasi F; Gaigalas AK; Hoffman RA; Flagler D; Marti GE
Cytometry B Clin Cytom; 2007 Nov; 72(6):442-9. PubMed ID: 17474131
[TBL] [Abstract][Full Text] [Related]
18. A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable.
Froebel KS; Raab GM; D'Alessandro C; Armitage MP; MacKenzie KM; Struthers M; Whitelaw JM; Yang S
Clin Exp Immunol; 2000 Oct; 122(1):72-8. PubMed ID: 11012621
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives. European Working Group on Clinical Cell Analysis.
Gratama JW; D'hautcourt JL; Mandy F; Rothe G; Barnett D; Janossy G; Papa S; Schmitz G; Lenkei R
Cytometry; 1998 Oct; 33(2):166-78. PubMed ID: 9773877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
